00867 CMS
- 7.820
- +0.220+2.89%
CMS News
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
CMS: Interim Report 2024
CMS: List of Directors and Their Role and Function
CMS: INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024
CMS: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024 AND RE-DESIGNATION OF DIRECTOR
CMS: Voluntary and Business Update Announcement New Drug Application for Additional Rheumatoid Arthritis (RA) Indication of Methotrexate Injection Approved in China
CMS: Notice of Board Meeting
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
CMS: LETTER TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY
CMS: LETTER TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
CMS: Voluntary and Business Update Announcement New Drug Application of Methylthioninium Chloride Enteric-coated Sustained-release Tablets Lumeblue Approved in China
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
CMS: Next Day Disclosure Return
CMS: FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
CMS: ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 9 MAY 2024
CMS: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
CMS: Next Day Disclosure Return
CMS: Voluntary and Business Update Announcement New Drug Application of Desidustat Tablets Accepted in China
Analysis
Price Target
No Data
No Data